Group One Trading, L.P. Checkpoint Therapeutics, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$1.02 - $10.6 $43,248 - $449,440	-42,400 Reduced 41.9%	58,794 $61,000
Q2 2022 Aug 11, 2022	SELL	$0.97 - $1.77 $72,210 - $131,765	-74,444 Reduced 42.38%	101,194 $104,000
Q1 2022 May 12, 2022	BUY	$1.53 - $3.25 $268,726 - $570,823	175,638 New	175,638 $311,000
Q4 2021 Feb 11, 2022	SELL	$2.68 - $4.46 $268 - $446	-100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.5 - $3.53 $250 - $353	100 New	100 $0

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.